Navigation Links
New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
Date:5/9/2008

tients with low back pain or pain from osteoarthritis of the knee or hip studied the tolerability of long-term exposure (90-days) to tapentadol IR. Patients were randomly assigned in a 4:1 ratio to a flexible dose of either tapentadol IR (50 or 100 mg/dose; maximum 600 mg/day) or oxycodone IR (10 or 15 mg/dose; maximum 90 mg/day) every four to six hours.

J&JPRD and Grunenthal GmbH supported this study.

J&JPRD and Ortho-McNeil-Janssen Pharmaceuticals, Inc. are wholly owned subsidiaries of Johnson & Johnson.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) is a wholly owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Europe, the United States and Asia. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. More information can be found at http://www.jnjpharmarnd.com/.

PriCara(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

PriCara(TM), a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a major health care company in the United States dedicated to the needs of primary care providers who serve a vital role on the frontline of medicine. For more information about the company, please visit http://www.PriCara.com.

Grunenthal

Grunenthal, a privately owned pharmaceutical company based in Aachen, Germany, discovered and started development of tapentadol. Grunenthal and J&JPRD have shared development responsibilities for tapentadol for acute and chronic pain conditions since the companies signed a licensing agreement for tapentadol in 2003.


'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
2. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
3. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
4. Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
5. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
6. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
7. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
8. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
9. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Dec. 22, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ... 910801.TW), China,s leading integrated healthcare enterprise, today announced that ... market, accumulating a total of 36,976,000 shares in December ... shares at a weighted average price of HK$0.83 per ...
... question confronting neuroscientists and computer vision researchers alike is how ...  Introspectively, we know that the human brain solves this problem ... know what it is. But teaching a computer ... research published this fall in the Public Library of ...
Cached Medicine Technology:Golden Meditech Further Repurchases Shares 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 3Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 4
(Date:6/2/2015)... Cincinnati, OH (PRWEB) June 02, 2015 ... healthcare ministry serving Ohio and Kentucky – has devoted ... Be Well videos to skin cancer prevention. One in ... concise video on Mercy Health’s YouTube channel, a Mercy ...     What are the main causes of skin cancer? ...
(Date:6/2/2015)... 02, 2015 First Choice Emergency ... rooms in the United States, named Kenneth Alan Totz, ... Jones Road facility. , “We are pleased to ... Road facility,” said Dr. James M. Muzzarelli, Executive Medical ... Totz received his undergraduate degree from St. Edwards University ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help from ... to support ovarian cancer research conducted by Cheng Wang, Ph.D. ... Colleen’s Dream Foundation Board of Directors. , Cundiff says the ... Colleen’s Dream Foundation and they couldn’t have picked a better ... a rising star in the ovarian cancer world,” says Cundiff. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 While the ... adaptions of comic books, comic books themselves are stepping ... Comics Uniting Nations plans to produce educational comics in ... Global Goals for Sustainable Development - an international effort ... poverty, hunger, health, education, sustainable energy, inequality, climate change ...
(Date:6/2/2015)... Barbara, CA (PRWEB) June 02, 2015 ... a scholarship fund set up by current and former ... Odajnyk, a beloved faculty member from 2002 until his ... integrity, keen intelligence, and depth of feeling, as well ... and fairytales. His capacities as an analyst, teacher, and ...
Breaking Medicine News(10 mins):Health News:Video provides helpful information about skin cancer prevention 2Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3
... to researchers from Wake Forest University School of ... restlessness associated with dementia are found to increase ... over-burdened or depressed. ,‘These symptoms are part ... them, but certain styles of caregiving may bring ...
... treatment methods for asthma attacks are found to be ... shows//. Spacer plays shorter stays in emergency departments usually ... Christopher Cates, M.D., of the University of Alberta, in ... children ages 2 years and older, and 614 adults ...
... resident doctors of Indira Gandhi Medical College, Shimla and ... light procession in protest against reservation to other backward ... and doctors also organized a blood donation camp in ... parallel OPDs. The medicos vowed to continue their struggle ...
... Prime Minister Manmohan Singh's appeal, the stalemate between government ... doctors persisted with their hunger strike for the tenth ... quo and we will continue our strike as government ... experts to review the reservation policy,' Dr Vinod Patro, ...
... brain tissue is possible in individuals exposed to lead after 18 ... of the American Academy of Neurology, May 23 2006. ,The ... had not been exposed to lead for an average of 18 ... of more than eight years. ,The researchers measured the ...
... eyesight to juvenile diabetes, has managed to urge scientists and ... her and thousands like herself to see despite failing visual ... was examined with a scanning laser ophthalmoscope, when she was ... a few years. "For a poet, that's an incredible feeling," ...
Cached Medicine News:Health News:Symptoms In Dementia Patients Negatively Correlates With The Characteristics Of Caregivers 2Health News:Spacers Score Over Nebulizers in Childhood Asthma Treatment 2Health News:Loss and damage to the brain cells possible with lead exposure in years ahead 2
Inquire...
...
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein....
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: